US Stem Cell Inc (USRM)

[gypsydoc]

Re-positioning with an RS and name change has a variety of benefits related to perpetuating this companies achieving its publicly stated goals. As a chiropractor in the sports med world, and knowing what I know and see happening with a tremendous interest and uptick of utilization in the orthopedic stem cell market, I am certain that the US Stem Cell positioning taking place in that market will create a revenue stream that will allow the company to reach the highest levels of theirs and my most confident expectations.